Biogen Inc
(BUE:BIIB)
ARS
18636
201.5 (1.09%)
Market Cap: 28.98 Til
Enterprise Value: 34.17 Til
PE Ratio: 27.95
PB Ratio: 2.13
GF Score: 49/100 Biogen Inc Pre-Recorded Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD Transcript
Mar 10, 2021 / 11:45AM GMT
Release Date Price:
ARS3070
(-2.57%)
Laura Nisenbaum
Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD
Mar 10, 2021 / 11:45AM GMT
=====================
Corporate Participants
=====================
* Laura Nisenbaum
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot